Ptc Therapeutics, Inc. financial data

Symbol
PTCT on Nasdaq
Location
500 Warren Corporate Center Drive, Warren, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 298 % +42.3%
Quick Ratio 4.93 % -7.67%
Debt-to-equity -686 % -130%
Return On Assets 31.2 %
Operating Margin 43.6 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 80.3M shares +4.1%
Common Stock, Shares, Outstanding 79.9M shares +3.87%
Entity Public Float 1.73B USD -25.6%
Common Stock, Value, Issued 79K USD +3.95%
Weighted Average Number of Shares Outstanding, Basic 78.5M shares +2.01%
Weighted Average Number of Shares Outstanding, Diluted 87.1M shares +13.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.78B USD +97.5%
Research and Development Expense 447M USD -15.9%
Operating Income (Loss) 776M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 741M USD +76.5%
Income Tax Expense (Benefit) -10.7M USD -139%
Net Income (Loss) Attributable to Parent 752M USD
Earnings Per Share, Basic 9 USD/shares
Earnings Per Share, Diluted 8 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 673M USD +27.9%
Marketable Securities, Current 1.02B USD +108%
Inventory, Net 52.7M USD +47.7%
Assets, Current 2.01B USD +56.7%
Property, Plant and Equipment, Net 57M USD -9.82%
Operating Lease, Right-of-Use Asset 80.7M USD +35.7%
Intangible Assets, Net (Excluding Goodwill) 396M USD +20%
Goodwill 82.3M USD 0%
Assets 2.64B USD +43.5%
Accounts Payable, Current 36.6M USD +175%
Employee-related Liabilities, Current 49.5M USD +7.05%
Contract with Customer, Liability, Current 1.69M USD
Liabilities, Current 866M USD +41.8%
Deferred Income Tax Liabilities, Net 55.9M USD +7.67%
Operating Lease, Liability, Noncurrent 95.5M USD +15.4%
Other Liabilities, Noncurrent 2.58M USD +3249%
Liabilities 2.8B USD -3.35%
Accumulated Other Comprehensive Income (Loss), Net of Tax 5.93M USD
Retained Earnings (Accumulated Deficit) -2.83B USD +21%
Stockholders' Equity Attributable to Parent -156M USD +85.2%
Liabilities and Equity 2.64B USD +43.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 870M USD +1130%
Net Cash Provided by (Used in) Financing Activities 9.41M USD +1643%
Net Cash Provided by (Used in) Investing Activities -184M USD -60.4%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 79.9M shares +3.87%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 701M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 686M USD +27.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.16M USD -41.2%
Deferred Tax Assets, Valuation Allowance 858M USD +2.85%
Deferred Tax Assets, Gross 869M USD +3.33%
Operating Lease, Liability 107M USD +10.8%
Payments to Acquire Property, Plant, and Equipment 1.72M USD -82%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 762M USD
Lessee, Operating Lease, Liability, to be Paid 160M USD -15.7%
Property, Plant and Equipment, Gross 94.3M USD -31.8%
Operating Lease, Liability, Current 11.8M USD -16.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.5M USD +1.78%
Lessee, Operating Lease, Liability, to be Paid, Year One 18.3M USD +12.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -12.4%
Deferred Income Tax Expense (Benefit) 2K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 52.5M USD -43.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.1M USD -20.5%
Unrecognized Tax Benefits 108M USD +7840%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.62M USD -57.5%
Operating Lease, Payments 3.39M USD -14.2%
Additional Paid in Capital 2.67B USD +5.4%
Amortization of Intangible Assets 18.7M USD -86.1%
Depreciation, Depletion and Amortization 7.22M USD -87%
Deferred Tax Assets, Net of Valuation Allowance 11.7M USD +56.9%
Share-based Payment Arrangement, Expense 73.3M USD -0.83%